Michaels Posts Solid Beat on Top and Bottom Lines
Michaels Companies reported better-than-expected fiscal fourth-quarter financial results before the markets opened on Thursday.
All Work
Chris Lange
FedEx Soars on Solid Earnings and Guidance
FedEx reported better-than-expected fiscal third-quarter financial results after the markets closed on Wednesday.
Nike Unveils the Future of Sport
Nike is taking steps as the world’s largest and most innovative sports brand to pioneer new technology in all sports.
Regeneron and Sanofi Plan to Appeal Amgen Patent Verdict
Regeneron Pharmaceuticals saw its shares halted on Wednesday afternoon after a jury ruled in favor of Amgen on a cholesterol drug patent.
4 More Key FDA Decisions in March
24/7 Wall St. has collected a few more U.S. Food and Drug Administration (FDA) decisions coming up in March.
What to Look for in Adobe Earnings
Adobe Systems is set to report its fiscal first-quarter financial results after the markets close on Thursday.
What to Expect From Aeropostale Earnings
Aeropostale is scheduled to report its fiscal fourth-quarter financial results after the markets close on Thursday.
Bio Blast Pharma Explodes on Positive Results
Bio Blast Pharma was blowing away all the other bulls in Wednesday’s session, with its stock up over 150% on positive clinical results.
How Analysts Rate Oracle After Earnings
Following Oracle's fiscal third-quarter report, a few analysts have decided to give their two cents on the stock.
Cerus Tumbles Despite FDA Approval
Shares of Cerus dropped just after the open of Wednesday’s regular trading session despite a key FDA approval.
SEC Charges Boston Man in Bridge Loan Ponzi Scheme
The SEC has charged a former Boston resident with operating a $10 million Ponzi scheme that claimed to generate profits from "bridge loans" to businesses in Jamaica.
Oracle Impresses With Earnings
Oracle reported better-than-expected fiscal third-quarter financial results after the markets closed Tuesday.
SEC Charges Municipal Advisor for Failing to Disclose Conflict of Interest
The SEC has charged Kansas-based Central States Capital Markets, its chief executive officer and two employees for breaching their fiduciary duty by failing to disclose a conflict of interest to a municipal client.
Celator Pharma Skyrockets on Breakthrough Trial Results
Celator Pharmaceuticals has announced positive results from its Phase 3 trial of Vyxeos Liposome for Injection in patients with high-risk (secondary) acute myeloid leukemia.
What to Look for in FedEx Earnings
FedEx is scheduled to report its fiscal third-quarter financial results Wednesday after the markets close.
SEC Charges Microcap With Misleading Investors
The SEC has charged a microcap company's CEO for falsely claiming to have a lucrative relationship with the United Nations and billions of dollars in clean energy contracts with foreign governments.
SEC Settles With AIG Affiliates
The SEC has announced charges against three AIG affiliates for steering mutual fund clients toward more expensive share classes so the firms could collect more fees.
Aeglea BioTherapeutics Prepares for IPO
Aeglea BioTherapeutics has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids
One analyst firm believes the development of abuse-deterrent formulations (ADF) of opioids creates a risk that older non-ADFs may be removed from the market, creating a huge risk and opportunity in the space.
Valeant Pharma Trips Over Preliminary Earnings and Guidance
Valeant Pharmaceuticals International reported mixed preliminary fourth-quarter financial results before the markets opened on Tuesday.